Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

DAIC's Top 10 for June

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June:

1. Med ...

July 02, 2024

Philip B. Adamson, MD, MSc, FACC, FESC, FRCP (Ed) has been appointed as Chief Medical Officer

News | Cardiovascular Business

CVRx Announces Key Senior Leadership Team Hires

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

July 01, 2024

Partially calcified valve leaflet tissue, including unaltered collagen (blue), calcified collagen (yellow to red) and aggregated calcium phosphate nodules.

News | Heart Failure

Study Defines the Process of and Defenses Against Cardiac Valve Calcification

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

June 27, 2024

New analysis by the American Heart Association and the McKinsey Health Institute reveals the burden of cardiovascular disease for women in the U.S. and proposes solutions to improve care

News | Womens Cardiovascular Health

Gender Gaps in Cardiovascular Disease Diagnosis and Treatment Persist

June 27, 2024 — Cardiovascular disease is the leading cause of death for women, and gaps in care and access persist ...

June 27, 2024

Despite greater weight loss in women, the improvement in HF symptoms was similar between sexes, suggesting semaglutide's heart failure benefits may be, in part, independent of weight loss

News | Cardiovascular Clinical Studies

Semaglutide Leads to Greater Weight Loss in Women than Men with HF, Improves HF Symptoms in Both Sexes

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

June 26, 2024

Backed by definitive clinical evidence from the PROACTIVE-HF pivotal trial, the company is planning a U.S. launch of Cordella this year

News | Heart Failure

Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure

June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...

June 24, 2024

New analysis of the pivotal Phase 3 SOLOIST-WHF trial demonstrates INPEFA cost-effectiveness

News | Cardiovascular Clinical Studies

Analysis of INPEFA (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

June 21, 2024

Following FDA approval to commence the clinical trial, an official site initiation has taken place as preparation for patient enrollment advances

News | Cardiovascular Clinical Studies

Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

June 20, 2024

Dr. Rahul Doshi leads ‘BACKBEAT’ clinical trial to prevent strokes and heart attacks by precisely timing heartbeats

News | Cardiovascular Clinical Studies

HonorHealth Research Institute Study Uses New Programing for Pacemakers to Control High Blood Pressure Without Additional Drugs

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

June 20, 2024

atHeart Medical’s reSept ASD Occluder is designed to preserve patients’ future transseptal treatment options

News | Structural Heart Occluders

Promising Long- and Short-term Clinical Data Show Potential of First ASD Occluder with a Bioresorbable, Metal-free Frame

June 20, 2024 — atHeart Medical, a medical device company establishing a new standard of care for atrial septal defects ...

June 20, 2024

News | Stents

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

June 12, 2024

The prevalences of atrial fibrillation (AF) and obesity continue to increase in parallel

News | Atrial Fibrillation

Comparative Study on Dual vs Single Cardioversion for Atrial Fibrillation in Obese Patients

June 12, 2024 — A team of Ochsner Health cardiologists recently published an article in the Journal of the American ...

June 12, 2024

Society of NeuroInterventional Surgery issues update to standards and guidelines following research in favor of minimally invasive procedure for deadly type of stroke

News | Stroke

Multiple Randomized Trials Prove More Stroke Patients Can Benefit from Thrombectomy

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion ...

June 07, 2024

Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million patients globally

News | Heart Failure

New Study Suggests that Amyloid Contributes to Calcific Aortic Valve Disease Development

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

June 07, 2024

Radial artery delivery is a means by which cardiac catheters are advanced through a blood vessel in a patient’s wrist to treat the heart

News | Heart Failure

BioCardia Announces United States Patent Issuance on Intramyocardial Delivery of Cell Aggregates to the Heart Including Minimally Invasive Radial Artery Approach

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

June 07, 2024